Zdrowie i gospodarka · 16/07/2019

FDA Requests Public Comment on Proposed Collection of Information for Drug Labeling Guidance

The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to its guidance on drug labeling for cardiovascular outcome claims, specifically for drugs used to treat hypertension.